Hexachimie

Hexachimie is a French pharmaceutical manufacturing company based in Méru, specializing in the production of active pharmaceutical ingredients (APIs) and chemical intermediates. Founded in 1964, the company became a key production site for Schering AG and was subsequently integrated into Bayer following its acquisition of Schering in 2006. The facility is primarily focused on complex chemical synthesis, supporting the production of contrast agents and hormonal treatments. As a subsidiary of Bayer, Hexachimie operates as a high-tech industrial site within the group's global supply chain, adhering to rigorous Good Manufacturing Practice (GMP) standards. The site is recognized for its expertise in industrial-scale chemical processes and its significant contribution to Bayer's radiology and women's healthcare portfolios.